Cargando…

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases

BACKGROUND: Synchronous metastases of colorectal cancer (CRC) are considered to be of worse prognostic value compared with metachronous metastases, but only few and conflicting data have been reported on this issue. METHODS: We retrospectively investigated patient demographics, primary tumour charac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mekenkamp, L J M, Koopman, M, Teerenstra, S, van Krieken, J H J M, Mol, L, Nagtegaal, I D, Punt, C J A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906733/ https://www.ncbi.nlm.nih.gov/pubmed/20551951 http://dx.doi.org/10.1038/sj.bjc.6605737

Ejemplares similares

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
por: Koopman, M, et al.
Publicado: (2009)

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
por: Yun, Sumi, et al.
Publicado: (2021)

The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)
por: ’t Lam - Boer, Jorine, et al.
Publicado: (2014)

The Distinction of Clinicopathological Characteristics, Treatment Strategy and Outcome in Colorectal Cancer Patients With Synchronous vs. Metachronous Bone Metastasis
por: Ma, Chen-xi, et al.
Publicado: (2020)

Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers
por: Jeong, Shinseok, et al.
Publicado: (2017)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population‐based study
por: Väyrynen, V., et al.
Publicado: (2020)

Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites
por: Kim, Joo Hoon, et al.
Publicado: (2010)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
por: Mekenkamp, Leonie JM, et al.
Publicado: (2012)

MicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls
por: Dijkstra, J R, et al.
Publicado: (2012)

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
por: Zheng, Peng, et al.
Publicado: (2018)

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer
por: Bartolini, Ilenia, et al.
Publicado: (2018)

Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
por: Bakkers, C., et al.
Publicado: (2021)

Synchronous and metachronous liver metastases in patients with colorectal cancer—towards a clinically relevant definition
por: Engstrand, Jennie, et al.
Publicado: (2019)

Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent
por: Mekenkamp, Leonie J. M., et al.
Publicado: (2014)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials
por: Goey, Kaitlyn K H, et al.
Publicado: (2017)

Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection
por: Jang, Mi Young, et al.
Publicado: (2013)

The Clinical Implication of Cancer-Associated Microvasculature and Fibroblast in Advanced Colorectal Cancer Patients with Synchronous or Metachronous Metastases
por: Kwak, Yoonjin, et al.
Publicado: (2014)

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2023)

Clinicopathological features and surgical options for synchronous colorectal cancer
por: Lee, Byoung Chul, et al.
Publicado: (2017)

MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer
por: Simmer, Femke, et al.
Publicado: (2015)

Reduced rate of copy number aberrations in mucinous colorectal carcinoma
por: Hugen, Niek, et al.
Publicado: (2015)

Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer
por: Shibukawa, Narihiro, et al.
Publicado: (2017)

Renal Cell Carcinoma with Synchronous Metastasis to the Calcaneus and Metachronous Metastases to the Ovary and Gallbladder
por: Decoene, Jasper, et al.
Publicado: (2011)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma
por: Dietz, Michelle V., et al.
Publicado: (2022)

Synchronous Advanced Colorectal Neoplasia: Clinicopathologic Features and Prognostic Significance
por: Anannamcharoen, Sahaphol, et al.
Publicado: (2023)

Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation
por: Tol, J., et al.
Publicado: (2008)

Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection
por: Garajova, Ingrid, et al.
Publicado: (2021)

Estimating changes in the rate of synchronous and metachronous metastases over time: Analysis of SEER data
por: Yilmaz, Ugur, et al.
Publicado: (2017)

Two rare cases of synchronous and metachronous colonic metastases in patients with advanced gastric cancer
por: Su, Wei-Chih, et al.
Publicado: (2018)

Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation
por: Serio, Gabriella, et al.
Publicado: (2022)

Clinicopathological features of small T1 colorectal cancers
por: Takashina, Yuki, et al.
Publicado: (2021)

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020)

Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database
por: Qiu, Ruiyue, et al.
Publicado: (2019)

Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum
por: Nash, GF, et al.
Publicado: (2012)

A rare case of metachronous neuroendocrine tumor after a colorectal adenocarcinoma: qualitative critical review of synchronous and metachronous gastrointestinal NET
por: Lancellotti, Francesco, et al.
Publicado: (2020)

Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
por: Kim, Kyu-pyo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ovacracefm0v9thoilutkftcq1